141 related articles for article (PubMed ID: 15103683)
1. Change in relative mobility of M protein following neuraminidase treatment in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Kurihara Y; Iijima S; Fukushima K; Hosaka T; Shiba K
J Clin Lab Anal; 2004; 18(3):182-6. PubMed ID: 15103683
[TBL] [Abstract][Full Text] [Related]
2. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
Papadea C; Reimer CB; Check IJ
Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis.
Kurihara Y; Shiba K; Fukumura Y; Kobayashi I; Kamei S
J Clin Lab Anal; 2000; 14(2):64-9. PubMed ID: 10683616
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous analysis of serum immunoglobulins in patients with M protein using cellulose acetate membrane isoelectric focusing.
Iijima S; Shiba K; Kurihara Y; Kamei S; Kimura S; Kimura M; Fukumura Y; Kobayashi I
J Clin Lab Anal; 1999; 13(4):145-50. PubMed ID: 10414593
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
6. Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma.
New HD; Callen JP
Arch Dermatol; 2011 Mar; 147(3):323-8. PubMed ID: 21422340
[TBL] [Abstract][Full Text] [Related]
7. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
8. Antibodies contained in "M" component of some patients with multiple myeloma are directed to food antigens?
Juranić Z; Radic J; Konic-Ristic A; Jelic S; Besu I; Mihaljevic B
Leuk Res; 2006 Dec; 30(12):1585-6. PubMed ID: 16516966
[TBL] [Abstract][Full Text] [Related]
9. [Use of agarose gel and cellulose acetate electrophoresis for detecting and identifying monoclonal immunoglobulins].
Pushkarev IA; Borisov LL; Peters VH; Storch H; Guseva LN
Lab Delo; 1979; (10):606-9. PubMed ID: 94130
[No Abstract] [Full Text] [Related]
10. Myeloma with two monoclonal IgG and IgD in serum: a case report.
Franck P; Petitpain N; Guerci AP; Denisart S; Jacob C; Guéant JL
Acta Haematol; 1994; 92(3):144-7. PubMed ID: 7871954
[TBL] [Abstract][Full Text] [Related]
11. IgE response in multiple myeloma.
Tamir R; Barchat I; Weiss H; Pick AI
Ann Allergy; 1993 Mar; 70(3):214-7. PubMed ID: 8452316
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of serum IgM and IgA monoclonal protein measurements by densitometry.
Tseng CH; Chang CY; Liu KS; Liu FJ
Ann Clin Lab Sci; 2003; 33(2):160-6. PubMed ID: 12817620
[TBL] [Abstract][Full Text] [Related]
13. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
[TBL] [Abstract][Full Text] [Related]
16. Light-heavy chain deposition disease progressing to multiple myeloma.
Daliani D; Weber D; Alexanian R
Am J Hematol; 1995 Dec; 50(4):296-8. PubMed ID: 7485106
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Mellemkjaer L; Salling Ibsen J; Sørensen HT; Olsen JH; Pedersen JO; Dahlerup JF
Am J Hematol; 2000 Jan; 63(1):1-6. PubMed ID: 10602159
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy in a tertiary referral hospital.
Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
[TBL] [Abstract][Full Text] [Related]
19. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS.
Preuss KD; Pfreundschuh M; Ahlgrimm M; Fadle N; Regitz E; Murawski N; Grass S
Int J Cancer; 2009 Aug; 125(3):656-61. PubMed ID: 19405124
[TBL] [Abstract][Full Text] [Related]
20. Double gammopathies: incidence and clinical course of 20 patients.
Nilsson T; Norberg B; Rudolphi O; Jacobsson L
Scand J Haematol; 1986 Jan; 36(1):103-6. PubMed ID: 3081993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
